| Status | 已發表Published |
| 自主研发还是外部获取？中国生物制药商业模式的技术考量 | |
| Alternative Title | Independent R&D or external acquisition? Technical considerations for the business model of Chinese biopharmaceuticals |
Shi, Y ; Hu, H.  ; Wang, Y. T.
| |
| 2012-09-01 | |
| Source Publication | 管理案例研究与评论
 |
| ISSN | 1674-1692 |
| Pages | 26-33 |
| Abstract | While biotechnology is coming to be they key, |
| Keyword | business model biopharmaceutical industry |
| Language | 其他語言Others |
| The Source to Article | PB_Publication |
| PUB ID | 14174 |
| Document Type | Journal article |
| Collection | Institute of Chinese Medical Sciences |
| Corresponding Author | Hu, H. |
| Recommended Citation GB/T 7714 | Shi, Y,Hu, H.,Wang, Y. T.. 自主研发还是外部获取？中国生物制药商业模式的技术考量[J]. 管理案例研究与评论, 2012, 26-33. |
| APA | Shi, Y., Hu, H.., & Wang, Y. T. (2012). 自主研发还是外部获取？中国生物制药商业模式的技术考量. 管理案例研究与评论, 26-33. |
| MLA | Shi, Y,et al."自主研发还是外部获取？中国生物制药商业模式的技术考量".管理案例研究与评论 (2012):26-33. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment